Interstitial lung disease in systemic sclerosis (systemic scleroderma)
In systemic sclerosis (SSc), interstitial lung disease (ILD) is common (>80%) and worsens the prognosis of the disease, but severe progressive damage develops only in 8–10% of cases. Interstitial changes in the lungs occur early (within the first 3–5 years of the disease). The histological ma...
Saved in:
Main Authors: | L. P. Ananyeva, I. E. Tyurin, O. A. Koneva, L. A. Garzanova, A. M. Lila |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2021-03-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1114 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA
by: L P Anan'eva, et al.
Published: (2011-04-01) -
SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION
by: Lyudmila Valeryevna Teplova, et al.
Published: (2010-06-01) -
Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01) -
IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01) -
Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease
by: Olga Borisovna Ovsyannikova, et al.
Published: (2013-06-01)